How are the world’s largest pharmaceutical companies adapting their R&D strategies to incorporate new technology that is putting the emphasis back on the patient?
Mobile health (mHealth) is just beginning to influence drug development.
We'll discuss the challenges, opportunities and value that a patient-centric model presents for drug development.
I recently participated in a webinar on patient-centric trials with ISR president Andrew Schafer and patient advocate Steve Smith. The webinar — Capturing the Patient Voice: ePRO, Real World Data and the Future of Clinical Trials — considered how clinical trial design can improve to include a more patient-focused approach.